Image may be NSFW.
Clik here to view.
Clik here to view.
Stereotaxis sees Japanese reimbursement by year end
After receiving regulatory clearance in Japan of its Niobe Remote Magnetic Navigation system for cardiac ablations last March, Stereotaxis (NASDAQ:STXS) now expects to achieve reimbursement approval by...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Neovasc launching Reducer in Europe for RA
Neovasc (NASDAQ:NVCN; TSX:NVC) has begun an initial launch in Europe to introduce its implantable Reducer medical device for the treatment of refractory angina (RA) in advanced-stage cardiovascular...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Rodman starts CorMedix at buy
Rodman & Renshaw has initiated coverage of CorMedix (NYSE:CRMD) with a “buy” rating and price target of $6.50. The stock closed at $2.48 on Wednesday. CorMedix is developing a novel catheter lock...
View Article
More Pages to Explore .....
